These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 6143042

  • 21. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M.
    N Engl J Med; 1998 May 14; 338(20):1405-12. PubMed ID: 9580647
    [Abstract] [Full Text] [Related]

  • 22. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
    Gorse GJ, Belshe RB, Munn NJ.
    J Clin Microbiol; 1986 Sep 14; 24(3):336-42. PubMed ID: 3531226
    [Abstract] [Full Text] [Related]

  • 23. Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine.
    Clements ML, Tierney EL, Murphy BR.
    J Clin Microbiol; 1985 Jun 14; 21(6):997-9. PubMed ID: 4008629
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.
    Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M.
    J Pediatr; 2000 Feb 14; 136(2):168-75. PubMed ID: 10657821
    [Abstract] [Full Text] [Related]

  • 25. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
    Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, Kemble G, Subbarao K.
    Vaccine; 2009 Jun 08; 27(28):3744-53. PubMed ID: 19464558
    [Abstract] [Full Text] [Related]

  • 26. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
    Belshe RB, Swierkosz EM, Anderson EL, Newman FK, Nugent SL, Maassab HF.
    J Infect Dis; 1992 Apr 08; 165(4):727-32. PubMed ID: 1552202
    [Abstract] [Full Text] [Related]

  • 27. Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine.
    Zahradnik JM, Kasel JA, Martin RR, Six HR, Cate TR.
    J Med Virol; 1983 Apr 08; 11(4):277-85. PubMed ID: 6875521
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.
    Murphy BR, Rennels MB, Douglas RG, Betts RF, Couch RB, Cate TR, Chanock RM, Kendal AP, Maassab HF, Suwanagool S, Sotman SB, Cisneros LA, Anthony WC, Nalin DR, Levine MM.
    Infect Immun; 1980 Aug 08; 29(2):348-55. PubMed ID: 7216417
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct 08; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 30. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, Treanor J, Zangwill K, Hayden FG, Bernstein DI, Kotloff K, King J, Piedra PA, Block SL, Yan L, Wolff M.
    J Infect Dis; 2000 Mar 08; 181(3):1133-7. PubMed ID: 10720541
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group.
    Gruber WC, Belshe RB, King JC, Treanor JJ, Piedra PA, Wright PF, Reed GW, Anderson E, Newman F.
    J Infect Dis; 1996 Jun 08; 173(6):1313-9. PubMed ID: 8648202
    [Abstract] [Full Text] [Related]

  • 32. [COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA].
    Kashirina OS, Chernikova MI, Vasiliev YM.
    Zh Mikrobiol Epidemiol Immunobiol; 2015 Jun 08; (3):38-46. PubMed ID: 26259268
    [Abstract] [Full Text] [Related]

  • 33. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM, Yi T, Ambrose CS.
    Vaccine; 2011 Jun 10; 29(26):4322-7. PubMed ID: 21513761
    [Abstract] [Full Text] [Related]

  • 34. Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.
    Cate TR, Couch RB.
    Infect Immun; 1982 Oct 10; 38(1):141-6. PubMed ID: 7141686
    [Abstract] [Full Text] [Related]

  • 35. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH, Seo SU, Song JM, Lee CM, Kim HA, Seong BL.
    Vaccine; 2006 Mar 10; 24(11):1966-74. PubMed ID: 16343703
    [Abstract] [Full Text] [Related]

  • 36. Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes.
    Wright PF, Bhargava M, Johnson PR, Thompson J, Karzon DT.
    Vaccine; 1985 Sep 10; 3(3):305-8. PubMed ID: 3904259
    [Abstract] [Full Text] [Related]

  • 37. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial.
    Alexandrova GI, Budilovsky GN, Koval TA, Polezhaev FI, Garmashova LM, Ghendon YuZ, Romanova YR, Smorodintsev AA.
    Vaccine; 1986 Jun 10; 4(2):114-8. PubMed ID: 3524050
    [Abstract] [Full Text] [Related]

  • 38. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus.
    Feldman S, Wright PF, Webster RG, Roberson PK, Mahoney J, Thompson J, Doolittle M, Lott L, Johnson P, Christoph RC.
    J Infect Dis; 1985 Dec 10; 152(6):1212-8. PubMed ID: 3905983
    [Abstract] [Full Text] [Related]

  • 39. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.
    Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF.
    J Med Virol; 1985 Dec 10; 17(4):325-35. PubMed ID: 4078559
    [Abstract] [Full Text] [Related]

  • 40. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
    Powers DC, Sears SD, Murphy BR, Thumar B, Clements ML.
    J Clin Microbiol; 1989 Dec 10; 27(12):2666-71. PubMed ID: 2592535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.